Search

everythinglearnresearchcommunity

for

Search:↓

Insulin resistance is not more common in idiopathic hirsutism patients than in healthy individuals.

The main causes of hirsutism in Jordanian women are PCOS and idiopathic hirsutism.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Menopause can cause skin issues, and seeing a dermatologist helps.

The document says that hirsutism in women usually needs hair removal and hormone treatment to manage symptoms and improve well-being.

Removing both ovaries can treat increased testosterone and related symptoms in postmenopausal women with ovarian hyperthecosis.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Both finasteride and GnRH agonist treatments reduced hair growth in women with idiopathic hirsutism, but GnRH agonist was more effective.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

The study found that imaging might miss small ovarian tumors causing high testosterone, and suggested using certain testosterone levels and treatment responses to identify these tumors.

Ovarian stromal hyperplasia can cause high testosterone in postmenopausal women and is treated by removing the ovaries.

The testes control steroid production through complex interactions involving various cells and signaling molecules.

Most patients improved with oral contraceptives, but some needed additional treatment.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

A postmenopausal woman's increased male hormone levels were successfully treated with surgery.

Transgender treatment includes hormones and surgery, but long-term effects are unknown and counseling is needed.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Male hormones and their interactions are crucial for male sexual development and characteristics.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

A 23-year-old woman's missed periods were caused by a rare genetic disorder treated with hormone patches.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Different drugs are used to manage breeding, prevent or end pregnancy, and treat reproductive issues in dogs and cats.

Ovarian hyperthecosis should be considered in young women with severe male-like symptoms and can be managed with hormone treatments.

Nafarelin may effectively treat excessive hair growth in women by reducing certain hormone levels.

Using GnRHa agonists helps diagnose and treat ovarian hyperthecosis when surgery isn't possible.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.